Researchers have discovered a common link between abnormal proteins that cause damage to brain cells in Alzheimer’s (AD), Parkinson’s (PD) and Huntington’s (HD) disease patients. The discovery could help scientists understand the mechanism by which these neurodegenerative diseases spread, and possibly lead to a therapy that targets multiple diseases, according to a new study.

The study, “Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins,” was published in the journal Acta Neuropathologica.

Protein clumps are found inside brain cells of people with all three diseases. These clumps are the result of abnormal protein formation and can spread from cell to cell, ultimately causing cell death. Different proteins form aggregates in each disease: tau in AD, alpha-synuclein in PD, and huntingtin in HD.

A possible therapy would involve boosting a brain cell’s ability to degrade a clump of proteins and damaged vesicles. If we could do this in one disease, it’s a good bet the therapy would be effective in the other two diseases.
Edward Campbell, PhD, study senior author and associate professor in the Department of Microbiology and Immunology at Loyola University Chicago Stritch School of Medicine

The study demonstrated the ineffective cell response to the protein clumps. Although the cell targets both the ruptured vesicles and the protein aggregates, the proteins are able to resist degradation. “The cell’s attempt to degrade the proteins is somewhat like a stomach trying to digest a clump of nails,” Campbell said.

This common mechanism could potentially explain the spreading of disease processes and the disruption of normal brain functions in Alzheimer’s, Parkinson’s, Huntington’s and other neurodegenerative diseases. Although the study’s findings need to be confirmed in future studies, they suggest that a common therapy for diverse neurodegenerative diseases could be developed.



Read full article